159 related articles for article (PubMed ID: 8353078)
1. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
[TBL] [Abstract][Full Text] [Related]
2. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
4. [A case of invasive thymoma made resectable by preoperative chemotherapy].
Tanaka K; Murota Y; Ando T; Asano K; Yamaguchi T; Wada G
Kyobu Geka; 1996 Sep; 49(10):868-71. PubMed ID: 8828336
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
Iwasaki Y; Ohsugi S; Takemura Y; Nagata K; Harada H; Nakagawa M
Chest; 2002 Dec; 122(6):2249-52. PubMed ID: 12475873
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
8. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.
Lucchi M; Melfi F; Dini P; Basolo F; Viti A; Givigliano F; Angeletti CA; Mussi A
J Thorac Oncol; 2006 May; 1(4):308-13. PubMed ID: 17409875
[TBL] [Abstract][Full Text] [Related]
10. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and operation for invasive thymoma.
Rea F; Sartori F; Loy M; CalabrĂ² F; Fornasiero A; Daniele O; Altavilla G
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):543-9. PubMed ID: 8361199
[TBL] [Abstract][Full Text] [Related]
12. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone.
Yokoi K; Matsuguma H; Nakahara R; Kondo T; Kamiyama Y; Mori K; Miyazawa N
J Thorac Oncol; 2007 Jan; 2(1):73-8. PubMed ID: 17410014
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
15. Natural history and treatment of malignant thymoma.
Cowen D; Hannoun-Levi JM; Resbeut M; Alzieu C
Oncology (Williston Park); 1998 Jul; 12(7):1001-5; discussion 1006. PubMed ID: 9684271
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with a five-drug regimen for invasive thymoma.
Bjerrum OW; Kiss K; Daugaard G
Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
[TBL] [Abstract][Full Text] [Related]
17. The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen.
Weissferdt A; Moran CA
Lung; 2013 Aug; 191(4):379-83. PubMed ID: 23652348
[TBL] [Abstract][Full Text] [Related]
18. Thymoma. A retrospective study of 87 cases.
Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
Cancer; 1994 May; 73(10):2491-8. PubMed ID: 8174044
[TBL] [Abstract][Full Text] [Related]
19. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Berruti A; Tampellini M; Gorzegno G; Dogliotti L
Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
[No Abstract] [Full Text] [Related]
20. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; CalabrĂ³ F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]